Upcoming events

LOTUS™ Valve PPM Rate: New data shows a downward trend in Permanent Pacemaker Rate (PPM)

Sponsored by Boston Scientific

The LOTUS™ Valve System is a controlled mechanical expansion TAVI technology, designed to provide unmatched freedom from PVL, precise delivery and deployment, and predictable results.

Boston Lotus Valve - 30 days results

1. Data on file at BSC ( discharge/7 days not published)
2. N. Van Mieghem Respond EXT CRT 2016
3. I Meredith, FIM EDGE TCT 2016

30 Day Results from the LOTUS Edge Feasibility Trial Presented at ACC 2017

Boston Lotus Valve - 30 days results

Poster presented by D. Walters, MD at ACC 2017

30-day results from the LOTUS Edge Feasibility Trial suggest that the advantages of the first-generation LOTUS Valve System are conserved with the next generation LOTUS Edge Valve System with 100% technical success, 95% none or trace PVL, and low VARC events. The PPM rate of 9.5% provides an initial indication that the Depth Guard feature, which is intended to enable predictable placement, early anchoring during deployment, minimal depth of valve frame and a reduced interaction with the LVOT, may effectively reduce the PPM rate. Due to the limited size of cohort studied in the LOTUS Edge Feasibility Trial, further investigation of LOTUS Edge is ongoing.


The Lotus™ Valve System / LOTUS Edge™ Valve System may only be used in countries where it is approved for use. The Lotus™ Valve System / LOTUS Edge™ Valve System is not available for sale in the European Economic Area. For educational purposes only.


With an unrestricted educational grant from Boston Scientific


This case report does not reflect the opinion of PCR or PCRonline, nor does it engage their responsibility.